{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-30",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "0009-7224",
      "generic_name": "EQUINE THYMOCYTE IMMUNE GLOBULIN",
      "labeler_name": "Pharmacia & Upjohn Company LLC",
      "brand_name": "Atgam",
      "active_ingredients": [
        {
          "name": "EQUINE THYMOCYTE IMMUNE GLOBULIN",
          "strength": "50 mg/mL"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "0009-7224-02",
          "description": "5 AMPULE in 1 CARTON (0009-7224-02)  / 5 mL in 1 AMPULE (0009-7224-01)",
          "marketing_start_date": "19811117",
          "sample": false
        }
      ],
      "listing_expiration_date": "20261231",
      "openfda": {},
      "marketing_category": "BLA",
      "dosage_form": "INJECTION, SOLUTION",
      "spl_id": "a96a4454-b33e-409c-b58c-af3144b36dea",
      "product_type": "PLASMA DERIVATIVE",
      "route": [
        "INTRAVENOUS"
      ],
      "marketing_start_date": "19811117",
      "product_id": "0009-7224_a96a4454-b33e-409c-b58c-af3144b36dea",
      "application_number": "BLA103676",
      "brand_name_base": "Atgam",
      "pharm_class": [
        "Antibody-Surface Protein Interactions [MoA]",
        "Immunoglobulin G [EPC]",
        "Immunoglobulins [CS]",
        "Increased T Lymphocyte Destruction [PE]",
        "Lymphocyte Function Alteration [PE]"
      ]
    }
  ]
}